Halozyme
HALO
166 hedge funds and large institutions have $2.11B invested in Halozyme in 2017 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 66 increasing their positions, 54 reducing their positions, and 13 closing their positions.
817% more call options, than puts
Call options by funds: $63.7M | Put options by funds: $6.95M
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
35% more capital invested
Capital invested by funds: $1.56B → $2.11B (+$548M)
22% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 54
15% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 13
1% less funds holding
Funds holding: 167 → 166 (-1)
1.59% less ownership
Funds ownership: 87.22% → 85.64% (-1.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$7.71M |
| 2 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$6.54M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$5.93M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.37M |
| 5 |
Two Sigma Investments
New York
|
+$5.29M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TS
Third Security
Radford,
Virginia
|
-$23.5M |
| 2 |
First Eagle Investment Management
New York
|
-$12.9M |
| 3 |
MVP
Miller Value Partners
Sarasota,
Florida
|
-$10.6M |
| 4 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
-$8.17M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.11M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
176
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
| – | -$149K | -11,625 | Closed |
|
177
Arrowstreet Capital
Boston,
Massachusetts
| – | -$131K | -10,200 | Closed |
|
|
CFA
178
Carroll Financial Associates
Charlotte,
North Carolina
| – | -$12K | -1,000 | Closed |
|
179
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$2K | -154 | Closed |
|
HALO Hedge Fund Activity: Q3 2017 in Review
166 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q3 2017, worth a combined $2.11B — up 35% from $1.56B a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new HALO positions and 13 closed out — a net gain of 2 holders — while 66 added to existing stakes and 54 trimmed.
The largest buyer was BlackRock, adding an estimated $7.71M. The largest seller was Third Security, cutting an estimated $23.5M.
- 166 institutional investors held Halozyme (HALO) as of Q3 2017, down from 167 in Q2 2017.
- Funds reported $2.11B of Halozyme stock for Q3 2017, up 35% quarter-over-quarter.
- 15 funds opened new Halozyme positions in Q3 2017 and 13 closed out, a net change of +2 holders.
- The largest Halozyme buyer in Q3 2017 was BlackRock, an estimated $7.71M added.
- The largest Halozyme seller in Q3 2017 was Third Security, an estimated $23.5M sold.
Based on aggregated 13F filings for Q3 2017.